截止目前,引用Bioss产品发表的文献共24676篇,总影响因子115653.06分,发表在Nature, Science, Cell以及Immunity等顶级期刊的文献共58篇,合作单位覆盖了清华、北大、复旦、华盛顿大学、麻省理工学院、东京大学以及纽约大学等国际知名研究机构上百所。 我们每月收集引用Bioss产品发表的文献。若您在当月已发表SCI文章,但未被我公司收集,请致电Bioss,我们将赠予现金鼓励,金额标准请参考“发文章 领奖金”活动页面。 近期收录2023年2月引用Bioss产品发表的文献共307篇(图一,绿色柱),文章影响因子(IF) 总和高达2073.152,其中,10分以上文献42篇(图二)。 图一 图二
本文主要分享引用Bioss产品发表文章至Nature Nanotechnology, Immunity, Cancer Cell等期刊的8篇 IF>15 的文献摘要,让我们一起欣赏吧。
CELL [IF=66.85] Anti-GSTP1 pAb 作者单位:北京大学化学与分子工程学院,北京分子科学国家实验室,合成与功能生物分子中心 Signal Transduction and Targeted Therapy [IF=38.104] Anti-APOH pAb 作者单位:北京大学基础医学院生理学和病理生理学系,分子心血管科学教育部重点实验室 摘要:Hyperhomocysteinemia (HHcy) is a risk factor for chronic kidney diseases (CKDs) that affects about 85% CKD patients. HHcy stimulates B cells to secrete pathological antibodies, although it is unknown whether this pathway mediates kidney injury. In HHcy-treated 2-kidney, 1-clip (2K1C) hypertensive murine model, HHcy-activated B cells secreted anti-beta 2 glycoprotein I (β2GPI) antibodies that deposited in glomerular endothelial cells (GECs), exacerbating glomerulosclerosis and reducing renal function. Mechanistically, HHcy 2K1C mice increased phosphatidylethanolamine (PE) (18:0/20:4, 18:0/22:6, 16:0/20:4) in kidney tissue, as determined by lipidomics. GECs oxidative lipidomics validated the increase of oxidized phospholipids upon Hcy-activated B cells culture medium (Hcy-B CM) treatment, including PE (18:0/20:4 + 3[O], PE (18:0a/22:4 + 1[O], PE (18:0/22:4 + 2[O] and PE (18:0/22:4 + 3[O]). PE synthases ethanolamine kinase 2 (etnk2) and ethanolamine-phosphate cytidylyltransferase 2 (pcyt2) were increased in the kidney GECs of HHcy 2K1C mice and facilitated polyunsaturated PE synthesis to act as lipid peroxidation substrates. In HHcy 2K1C mice and Hcy-B CM-treated GECs, the oxidative environment induced by iron accumulation and the insufficient clearance of lipid peroxides caused by transferrin receptor (TFR) elevation and down-regulation of SLC7A11/glutathione peroxidase 4 (GPX4) contributed to GECs ferroptosis of the kidneys. In vivo, pharmacological depletion of B cells or inhibition of ferroptosis mitigated the HHcy-aggravated hypertensive renal injury. Consequently, our findings uncovered a novel mechanism by which B cell-derived pathogenic anti-β2GPI IgG generated by HHcy exacerbated hypertensive kidney damage by inducing GECs ferroptosis. Targeting B cells or ferroptosis may be viable therapeutic strategies for ameliorating lipid peroxidative renal injury in HHcy patients with hypertensive nephropathy. ACS Nano [IF=18.027] 文献引用抗体: bs-3884R; Anti-GPX4 pAb | WB
地 址: 北京市通州区马驹桥镇联东U谷西区四期67号楼 联系人: 秦 电 话: 4009019800 传 真: 010-58129612 Email:sales@bioss.com.cn
北京博奥森生物技术有限公司
商家主页